ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.91 Million USD | -86.68% |
| 2022 | 10.83 Million USD | -35.41% |
| 2021 | 16.78 Million USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 369.99 Thousand USD | 7.95% |
| 2024 Q2 | 344.96 Thousand USD | -6.04% |
| 2023 Q3 | 348.51 Thousand USD | 743.7% |
| 2023 Q2 | 41.3 Thousand USD | -93.93% |
| 2023 FY | 1.44 Million USD | -86.68% |
| 2023 Q1 | 680.85 Thousand USD | -73.55% |
| 2023 Q4 | 350.88 Thousand USD | 0.68% |
| 2022 Q4 | 2.57 Million USD | 23.57% |
| 2022 FY | 10.83 Million USD | -35.41% |
| 2022 Q3 | 2.08 Million USD | -26.13% |
| 2022 Q2 | 2.81 Million CAD | -24.74% |
| 2022 Q1 | 3.74 Million CAD | 42.05% |
| 2021 Q2 | 4.43 Million CAD | -18.9% |
| 2021 Q1 | 5.47 Million CAD | 0.0% |
| 2021 Q3 | 3.05 Million CAD | -31.13% |
| 2021 FY | 16.78 Million USD | 0.0% |
| 2021 Q4 | 2.63 Million USD | -13.72% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -109.65% |
| Arrayit Corporation | 4.37 Million USD | 56.272% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 92.598% |
| Bioqual, Inc. | 58.59 Million USD | 96.733% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 87.486% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.974% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 69.933% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -82.02% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 95.24% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -327.733% |
| InVitro International | 792.62 Thousand USD | -141.488% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 82.804% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 73.504% |
| NovelStem International Corp. | 12 Thousand USD | -15850.858% |
| Optigenex Inc. | 465.97 Thousand USD | -310.778% |
| PharmChem, Inc. | 6.01 Million USD | 68.164% |
| Proteome Sciences plc | 6.4 Million USD | 70.095% |
| Response Genetics, Inc | 18.04 Million USD | 89.39% |
| Rennova Health, Inc. | 13.03 Million USD | 85.317% |
| RushNet, Inc. | 1.78 Million USD | -7.06% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | 49.564% |
| Todos Medical Ltd. | 7.69 Million USD | 75.125% |